Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novavax Inc (NVAX) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

Novavax IncTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

Novavax Inc vs DENTSPLY SIRONA Inc — how do they compare? Novavax Inc trades at $7.96 (market cap $1.31B), while DENTSPLY SIRONA Inc trades at $11.69 (market cap $2.31B). The key difference: DENTSPLY SIRONA Inc is the larger of the two by market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.

NVAXXRAY
Market Cap
$1.31B$2.31B
Sector
HealthHealth
52-Week High
$11.19$14.68
52-Week Low
$6.22$9.64
Enterprise Value
$889.30M$4.39B
Dividend Yield
5.04%

Returns comparison

Trailing returns across standard periods

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY